共 8 条
[2]
BAKRI SJ, 2006, EYE 0505
[3]
Testing intravitireal toxicity of bevacizumab (Avastin)
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2006, 26 (03)
:257-261
[4]
Intravitreal bevacizumab (avastin) for refractory pseudophakic cystoid macular edema
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2006, 26 (03)
:356-357
[5]
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion
[J].
OPHTHALMIC SURGERY LASERS & IMAGING,
2005, 36 (04)
:336-339
[6]
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
[J].
OPHTHALMIC SURGERY LASERS & IMAGING,
2005, 36 (04)
:331-335
[7]
Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2006, 26 (03)
:262-269
[8]
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2006, 26 (03)
:275-278